Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Weir, RAP
  • Mcmurray, JJV
  • Granger, CB
  • Puu, M
  • Ostergren, J
  • Yusuf, Salim
  • Swedberg, K
  • Pfeffer, MA

publication date

  • August 1, 2006